DHR vs MSFT: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Microsoft Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
VS
Microsoft Corporation · Technology
$379.40
+45.0% upside to fair value
Grade A
High Quality
QuantHub Verdict
MSFT has more upside to fair value
(+45.0%).
MSFT trades at a lower forward P/E
(22.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MSFT |
| Current Price |
$195.98 |
$379.40 |
| Fair Value Estimate |
$211.54 |
$550.13 |
| Upside to Fair Value |
+7.9%
|
+45.0%
|
| Market Cap |
$138.7B |
$2,818.3B |
| Forward P/E |
37.8x
|
22.5x
|
| EV / EBITDA |
22.8x
|
14.2x
|
| Price / Sales |
5.6x
|
8.9x
|
| Price / FCF |
26.2x
|
38.6x
|
| Revenue Growth YoY |
+3.7%
|
+18.3%
|
| Gross Margin |
60.7%
|
68.3%
|
| Operating Margin |
21.0%
|
46.8%
|
| Return on Equity |
7.1%
|
33.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.81%
|
2.59%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Microsoft Corporation is a leading global technology company specializing in cloud computing, productivity software, and enterprise platforms. The company benefits from a very strong and widening competitive moat supported by scale, switching costs, an integrated ecosystem, and disciplined capital allocation including large buybacks and dividends. Its business quality is high, demonstrated by a 3…
Accumulation Zones
| Metric |
DHR |
MSFT |
| Zone Low |
$158.66 |
$412.60 |
| Zone High |
$179.81 |
$467.61 |
| In Buy Zone? |
No
|
Yes
|